Berliner Boersenzeitung - Six African nations to get own mRNA jab production

EUR -
AED 4.219139
AFN 82.403092
ALL 98.729742
AMD 448.134607
ANG 2.070253
AOA 1053.91474
ARS 1254.970392
AUD 1.795401
AWG 2.067623
AZN 1.955086
BAM 1.955399
BBD 2.319124
BDT 139.561364
BGN 1.955517
BHD 0.4329
BIF 3415.399205
BMD 1.148679
BND 1.502013
BOB 7.936957
BRL 6.660499
BSD 1.148664
BTN 97.795974
BWP 15.691917
BYN 3.755929
BYR 22514.114397
BZD 2.307227
CAD 1.590444
CDF 3304.749956
CHF 0.931918
CLF 0.028752
CLP 1103.317632
CNY 8.387982
CNH 8.403399
COP 4915.394026
CRC 577.481508
CUC 1.148679
CUP 30.440002
CVE 110.24238
CZK 25.072245
DJF 204.52735
DKK 7.465474
DOP 68.615921
DZD 151.542932
EGP 58.587475
ERN 17.23019
ETB 153.246751
FJD 2.586021
FKP 0.858412
GBP 0.858844
GEL 3.153125
GGP 0.858412
GHS 17.744274
GIP 0.858412
GMD 82.139786
GNF 9944.959424
GTQ 8.848184
GYD 240.957972
HKD 8.911064
HNL 29.77689
HRK 7.530395
HTG 150.239173
HUF 409.314634
IDR 19346.458909
ILS 4.27133
IMP 0.858412
INR 97.866845
IQD 1504.691257
IRR 48388.115317
ISK 144.894544
JEP 0.858412
JMD 182.052645
JOD 0.81476
JPY 161.087372
KES 149.040759
KGS 99.791537
KHR 4598.816169
KMF 497.958243
KPW 1033.880648
KRW 1636.787929
KWD 0.351162
KYD 0.957154
KZT 595.697771
LAK 24802.399424
LBP 102910.508687
LKR 344.469319
LRD 229.710868
LSL 21.411107
LTL 3.391752
LVL 0.694825
LYD 6.242719
MAD 10.587228
MDL 19.64714
MGA 5106.640987
MKD 61.485085
MMK 2411.701328
MNT 4066.241766
MOP 9.177217
MRU 45.507662
MUR 51.128109
MVR 17.684027
MWK 1991.708666
MXN 22.577579
MYR 5.044427
MZN 73.406341
NAD 21.411107
NGN 1842.400951
NIO 42.271326
NOK 11.892386
NPR 156.482892
NZD 1.915084
OMR 0.442265
PAB 1.148494
PEN 4.257027
PGK 4.752025
PHP 65.020421
PKR 322.416044
PLN 4.279983
PYG 9195.113283
QAR 4.187141
RON 4.976886
RSD 117.215949
RUB 93.42041
RWF 1654.860444
SAR 4.30866
SBD 9.564782
SCR 16.3455
SDG 689.762882
SEK 10.916686
SGD 1.502139
SHP 0.902682
SLE 26.161236
SLL 24087.212054
SOS 656.465302
SRD 42.673568
STD 23775.342459
SVC 10.049938
SYP 14935.071967
SZL 21.39461
THB 38.181525
TJS 12.23279
TMT 4.020378
TND 3.401002
TOP 2.690322
TRY 43.94882
TTD 7.801399
TWD 37.33784
TZS 3084.203974
UAH 47.767199
UGX 4204.137366
USD 1.148679
UYU 48.500048
UZS 14827.957496
VES 92.880635
VND 29848.431766
VUV 138.277951
WST 3.20172
XAF 655.788186
XAG 0.035177
XAU 0.000332
XCD 3.104363
XDR 0.815516
XOF 655.822434
XPF 119.331742
YER 281.713476
ZAR 21.386345
ZMK 10339.514707
ZMW 32.705581
ZWL 369.874268
  • RBGPF

    0.1400

    63.59

    +0.22%

  • RYCEF

    0.2100

    9.5

    +2.21%

  • BCC

    0.9530

    91.753

    +1.04%

  • CMSD

    0.2100

    22.03

    +0.95%

  • NGG

    1.2300

    74.13

    +1.66%

  • CMSC

    0.1450

    21.855

    +0.66%

  • SCS

    0.0400

    9.46

    +0.42%

  • RIO

    1.2800

    59.75

    +2.14%

  • BTI

    0.3850

    42.935

    +0.9%

  • GSK

    0.4350

    36.885

    +1.18%

  • RELX

    0.5200

    52.59

    +0.99%

  • JRI

    0.3100

    12.44

    +2.49%

  • VOD

    0.3850

    9.615

    +4%

  • BCE

    0.1200

    22.5

    +0.53%

  • BP

    0.7100

    28.79

    +2.47%

  • AZN

    1.1400

    68.04

    +1.68%

Six African nations to get own mRNA jab production
Six African nations to get own mRNA jab production

Six African nations to get own mRNA jab production

Six African countries have been chosen to establish their own mRNA vaccine production, the World Health Organization said Friday, with the continent largely shut out of access to Covid jabs.

Text size:

Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia were selected as the first recipients of technology from the WHO's global mRNA vaccine hub, in a push to ensure Africa can make its own jabs to fight the Covid and other diseases.

"More than 80 percent of the population of Africa is yet to receive a single dose. Much of this inequity has been driven by the fact that globally, vaccine production is concentrated in a few mostly high-income countries," WHO chief Tedros Adhanom Ghebreyesus told a ceremony on the sidelines of an EU-Africa summit in Brussels.

"One of the most obvious lessons of the Covid-19 pandemic, therefore, is the urgent need to increase local production of vaccines, especially in low and middle-income countries."

Tedros has continually called for equitable access to vaccines in order to beat the pandemic, and rails against the way wealthy nations have hogged doses, leaving Africa lagging behind other continents in the global vaccination effort.

- Self-reliance -

Currently only one percent of the vaccines used in Africa are produced on the continent of some 1.3 billion people.

The WHO set up a global mRNA technology transfer hub in South Africa last year to support manufacturers in low- and middle-income countries to produce their own vaccines.

The global hub's role is to ensure that manufacturers in those nations have the know-how to make mRNA vaccines at scale and according to international standards.

As used in the Pfizer/BioNTech and Moderna Covid-19 vaccines, mRNA technology provokes an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells.

Primarily set up to address the Covid-19 pandemic, the global hub has the potential to expand manufacturing capacity for other vaccines and products, such as insulin to treat diabetes, cancer medicines and, potentially, vaccines for diseases such as malaria, tuberculosis and HIV.

The scheme's ultimate goal is to spread capacity for national and regional production to all health technologies.

"The goal is in 2040 to have reached a level of 60% of vaccines produced in Africa that are administered in Africa," said EU chief Ursula von der Leyen.

- 'Back of the queue' -

The WHO said it would work with the first six countries chosen to develop a roadmap of training and support so they can start producing vaccines as soon as possible. Training will begin in March.

The South African hub is already producing mRNA vaccines at laboratory scale and is currently scaling up towards commercial scale.

But the announcement of the tech transfers does not solve the thorny issue of Covid-19 patents that has set Africa at loggerheads with Europe.

African -- and other developing -- nations are pushing at the World Trade Organization for the temporary intellectual property waiver to allow the generic production of vaccines and treatments.

Europe -- the home of some of the major companies behind the vaccines -- has opposed the move arguing that the first priority was to build up production capacity in poorer countries.

"We are talking about the lives of millions, hundreds of millions of people, rather than the profitability of the few companies," South African President Cyril Ramaphosa said.

"It is not acceptable that Africa is consistently at the back of the queue in relation to access to medicines."

French President Emmanuel Macron pushed back against the calls for a waiver, but mooted other options including "compulsory licensing" that could see the patents used in limited cases.

"We have to be consistent with everything we do, we have to protect intellectual property, because it's very important for us to continue to create, to innovate, to invent," Macron said.

"We have to make sure that this intellectual property never hinders the dissemination of knowledge and the building of its capacities."

(T.Burkhard--BBZ)